| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.46 | 6e-12 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |